Xinyuan Jia

发表

Oncolytic adenovirus-mediated intratumoral expression of TRAIL and CD40L enhances immunotherapy by modulating the tumor microenvironment in immunocompetent mouse models.

Xianghui Yu, Wenmo Liu, Jiaxin Wu, 2022, Cancer letters.

Dose-related immunomodulatory effects of recombinant TRAIL in the tumor immune microenvironment

Xianghui Yu, Wenmo Liu, Lizheng Wang, 2023, Journal of Experimental & Clinical Cancer Research.